SAR131675, a new potent selective VEGFR-3-TK inhibitor: Effect on lymphangiogenic, tumor growth, and metastasis.
Isabelle Blanc, Françoise Bono(OSE Immunotherapeutics (France)), M.C. Laplace, Olivier Duclos(Sanofi (France)), G. Guéguen(Sanofi (France)), Antoine Alam(Sanofi (France)), Paul Schaeffer(Universidad La Salle), Pierre Savi(Sanofi (France)), Jacques Bonnin(Sanofi (France)), F. Dol(Sanofi (France)), Pauline Barron(Sanofi (France))
Cited by 1
Related Papers
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
|Nature Medicine|2001|1.7k
PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic Steatosis
|PLoS Biology|2005|943
Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cells
|JCI Insight|2017|444
PGC-1α Coactivates PDK4 Gene Expression via the Orphan Nuclear Receptor ERRα: a Mechanism for Transcriptional Control of Muscle Glucose Metabolism
|Molecular and Cellular Biology|2005|355